Mannatech, Incorporated provides wellness solutions. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through network marketing channels and a Website. It has operations in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Phone972-471-7400
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$173.56 million
Profitability
Miscellaneous
Employees247
Next Earnings Date3/9/2020 (Estimated)
OptionableNot Optionable
Mannatech (NASDAQ:MTEX) Frequently Asked Questions
What is Mannatech's stock symbol?
Mannatech trades on the NASDAQ under the ticker symbol "MTEX."
How often does Mannatech pay dividends? What is the dividend yield for Mannatech?
Mannatech announced a quarterly dividend on Friday, February 14th. Shareholders of record on Friday, March 13th will be given a dividend of $0.125 per share on Friday, March 27th. This represents a $0.50 annualized dividend and a yield of 3.30%. The ex-dividend date of this dividend is Thursday, March 12th. View Mannatech's Dividend History.
How will Mannatech's stock buyback program work?
Mannatech announced that its board has approved a share buyback plan on Wednesday, November 14th 2018, which authorizes the company to repurchase $500,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 1.3% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's board believes its stock is undervalued.
How were Mannatech's earnings last quarter?
Mannatech, Inc. (NASDAQ:MTEX) released its quarterly earnings results on Wednesday, August, 7th. The company reported $0.81 earnings per share for the quarter. The firm earned $40.71 million during the quarter. Mannatech had a negative net margin of 0.24% and a negative return on equity of 1.52%. View Mannatech's Earnings History.
When is Mannatech's next earnings date?
Has Mannatech been receiving favorable news coverage?
Headlines about MTEX stock have been trending very negative on Saturday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Mannatech earned a daily sentiment score of -4.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the company's share price in the next few days. View News Stories for Mannatech.
Are investors shorting Mannatech?
Mannatech saw a increase in short interest during the month of February. As of February 14th, there was short interest totalling 2,000 shares, an increase of 1,900.0% from the January 30th total of 100 shares. Based on an average daily volume of 1,600 shares, the days-to-cover ratio is presently 1.3 days. Approximately 0.2% of the company's stock are sold short. View Mannatech's Current Options Chain.
Who are some of Mannatech's key competitors?
Some companies that are related to Mannatech include Happiness Biotech Group (HAPP), Sundial Growers (SNDL), Mediwound (MDWD), Natural Alternatives International (NAII), Cyanotech (CYAN), True Drinks (TRUU), FitLife Brands (FTLF), GLG Life Tech (GLGLF), Tauriga Sciences (TAUG), Nutra Pharma (NPHC), Entia Biosciences (ERGO), Beleave (BE), Beleave (BE) and Rock Creek Pharmaceuticals (RCPIQ).
What other stocks do shareholders of Mannatech own?
Who are Mannatech's key executives?
Mannatech's management team includes the folowing people:
- Mr. Alfredo Bala, CEO & Pres (Age 58)
- Mr. Joel R. Bikman, Chief Operating & Marketing Officer (Age 46)
- Mr. David A. Johnson, Chief Financial Officer (Age 49)
- Ms. Erin Kemmler Barta, Gen. Counsel & Corp. Sec. (Age 49)
- Mr. Landen Granvel Fredrick, Chief Global Sales Officer & Pres of North America (Age 46)
Who are Mannatech's major shareholders?
Mannatech's stock is owned by many different of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (1.54%). Company insiders that own Mannatech stock include Gerald E Gilbert, J Stanley Fredrick, Kevin Andrew Robbins and Larry A Jobe. View Institutional Ownership Trends for Mannatech.
Which major investors are buying Mannatech stock?
MTEX stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. Company insiders that have bought Mannatech stock in the last two years include Gerald E Gilbert, J Stanley Fredrick, Kevin Andrew Robbins and Larry A Jobe. View Insider Buying and Selling for Mannatech.
How do I buy shares of Mannatech?
Shares of MTEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Mannatech's stock price today?
One share of MTEX stock can currently be purchased for approximately $15.16.
How big of a company is Mannatech?
What is Mannatech's official website?
How can I contact Mannatech?
Mannatech's mailing address is 1410 LAKESIDE PARKWAY SUITE 200, FLOWER MOUND TX, 75028. The company can be reached via phone at 972-471-7400 or via email at [email protected]
MarketBeat Community Rating for Mannatech (NASDAQ MTEX)
MarketBeat's community ratings are surveys of what our community members think about Mannatech and other stocks. Vote "Outperform" if you believe MTEX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTEX will underperform the S&P 500 over the long term. You may vote once every thirty days.
